2017 International Congress

Thursday, June 8, 2017

1:15pm-2:45pm

Improvement in attention/memory domains in advanced Parkinson’s disease patients treated with levodopa-carbidopa intestinal gel is associated with better quality of life

D. Standaert, R. Rodriguez, J. Slevin, M. Lobatz, C. Hall, M. Facheris, J. Benesh, S. Dubow (Birmingham, AL, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

Improvement in hand tremor following carpal tunnel release surgery

A. Hollingsworth, S. Wijemanne (San Antonio, TX, USA)

Dystonia  ·  Exhibit Hall C

1:15pm-2:45pm

Improvement Observed in Children with combined GPi and VL Thalamus Deep Brain Stimulation for the Treatment of Secondary Dystonia

D. German, T. Sanger (Los Angeles, CA, USA)

Dystonia  ·  Exhibit Hall C

1:15pm-2:45pm

Improvement of memory guided saccade amplitude by the STN DBS and target eccentricity

A. YUGETA, Y. TERAO, Y. UGAWA (Tokyo, Japan)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C

1:15pm-2:45pm

Improvement on gait in Parkinson’s disease patients using Honda stride management assist device

N. Kawashima, M. Matsuhashi, T. Hamano, K. Nagami, T. Furukado, M. Iijima, M. Isogai, M. Komachi, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

Improving Clinical Trials Through Patient Input: Outcomes of a Partnership Between Pfizer and the Parkinson’s Disease Foundation

K. Schroeder, M. Fenney, D. Gray, T. Rolph, S. Sohur, V. Todaro (New York, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

Improving Racial and Ethnic Diversity in Parkinson`s Disease Clinical Trials

S. Ray, A. Madan, D. Burdick, A. Griffith, P. Agarwal (Kirkland, WA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C

1:15pm-2:45pm

In-patient Parkinson courses and caregiver burden

K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

Other  ·  Exhibit Hall C

1:15pm-2:45pm

Incorporating Specialist Independent Prescribing Pharmacist (SIPP) sessions into the Movement Disorder Service

D. Fletcher, E. Thomas, B. Mohamed (Cardiff, United Kingdom)

Other  ·  Exhibit Hall C